FindTrial
Sign In

Multimodal imaging characteristics of acute central serous chorioretinopathy with fibrinous exudation

Multimodal imaging characteristics of acute central serous chorioretinopathy with fibrinous exudation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103950
Enrollment
Unknown
Registered
2025-06-09
Start date
2025-06-10
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute central serous chorioretinopathy with fibrinous exudation

Interventions

study group:None
control group:None

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. acute CSC (duration of disease < 6 months); 2.OCT showing serous neurosensory detachment involving the macula with or without PED, FFA showing ink-blot or smoke-stack hyperfluorescent leakage.

Exclusion criteria

Exclusion criteria: 1. Chronic CSC; 2. Concomitant choroidal neovascularization (CNV) or other macular diseases; 3. Inability to perform fluorescein angiography (FFA) and potassium iodide angiography (ICGA) due to contrast media allergy; 4. History of glucocorticoid use or systemic immune disease.

Design outcomes

Primary

MeasureTime frame
subfoveal choroidal thickness;—

Countries

China

Contacts

Public ContactHanjin Dong

Tianjin Medical University Eye Hospital

djindonghan@126.com+86 13043234240

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026